上海阿拉丁生化科技股份有限公司 公司信息
公司名称:
上海阿拉丁生化科技股份有限公司
电话:
400-6206333
电子邮件:
market@aladdin-e.com
国籍:
中国
网址:
www.aladdin-e.com/
产品总数:
48466
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
公司提供产品列表
Telazorlimab (anti-TNFRSF4)
特拉佐利单抗
2126777-87-3
Dysprosium(III) trifluoromethanesulfonate
三氟甲烷磺酸镝
139177-62-1
Bis(hexamethylene)triamine
双(六甲撑)三胺
143-23-7
Dehydroepiandrosterone sulfate
硫酸脱氢表雄酮
651-48-9
Xentuzumab (anti-IGF1)
珍妥珠单抗
1417158-65-6
Meropenem-d6
美罗培南-d6
1133424-00-6
Imazapic
甲咪唑烟酸
104098-48-8
IDO-IN-13
GS-4361
2291164-02-6
Ethyl 2-oxo-4-phenylbutyrate
2-氧代-4-苯基丁酸乙酯
64920-29-2
Ranibizumab (anti-VEGFA)
雷尼株单抗
347396-82-1
Nadecnemab (anti-GFRA3)
NADECNEMAB (ANTI-GFRA3)
2377679-19-9
Benzyldiphenylphosphine
苄基二苯基膦
7650-91-1
Quetmolimab (anti-CX3CL1)
QUETMOLIMAB (奎莫利单抗 )
2084037-83-0
Codrituzumab (anti-GPC3)
考曲妥珠单抗
1365267-33-9
Bexmarilimab (anti-STAB1)
BEXMARILIMAB
2259301-27-2
Narsoplimab (anti-MASP2)
NARSOPLIMAB (纳索利单抗 )
2108782-45-0
8-Azahypoxanthine
8-氮杂次黄嘌呤
2683-90-1
Sirtratumab (anti-SLITRK6)
Sirtratumab
1824663-82-2
Rosmantuzumab (anti-RSPO3)
Rosmantuzumab
1684393-04-1
Bivatuzumab (anti-CD44v6)
比伐珠单抗
214559-60-1
Apelin 17 TFA
Apelin 17 TFA,Apelin受体(APJ)激动剂
217082-57-0
Tamrintamab (anti-DPEP3)
TAMRINTAMAB (他林妥单抗 )
2148325-59-9
Cinpanemab (anti-Alpha-synuclein)
CINPANEMAB (辛帕奈单抗 )
2094516-02-4
Mogamulizumab (anti-CCR4)
Mogamulizumab
1159266-37-1
Alizarin Yellow R sodium salt
茜素黄R钠盐
1718-34-9
2-(azetidin-1-yl)ethan-1-amine
2-(氮杂环丁烷-1-基)乙-1-胺
795299-77-3
Tesnatilimab (anti-NKG2D)
特拉佐利单抗
2242758-08-1
Lacnotuzumab (anti-M-CSF)
Lacnotuzumab
1831128-32-5
Tesidolumab (anti-Complement C5)
Tesidolumab
1531594-08-7
Sonepcizumab (anti-Sphingosine-1-phosphate)
SONEPCIZUMAB (ANTI-SPHINGOSINE-1-PHOSPHATE)
1031360-18-5
Urelumab (anti-TNFRSF9)
乌瑞芦单抗
934823-49-1
Elotuzumab (anti-SLAMF7)
埃罗妥珠单抗
915296-00-3
Galiximab (anti-CD80)
加利昔单抗
357613-77-5
Idactamab (anti-SLC1A5)
IDACTAMAB (ANTI-SLC1A5)
2245205-37-0
Apamistamab (anti-PTPRC)
Iodine (131I) Apamistamab
2097132-02-8
Ravulizumab (anti-Complement C5)
Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer
1803171-55-2
Itolizumab (anti-CD6)
伊利组单抗
1116433-11-4
Bimagrumab (anti-ACVR2B)
Bimagrumab
1356922-05-8
Lumiliximab (anti-FceR2)
LUMILIXIMAB ( 鲁昔单抗 )
357613-86-6
Vopratelimab (anti-ICOS)
伏派利单抗
2039148-04-2
KWAR23 (anti-SIRPg)
KWAR23 (ANTI-SIRPG)
2243227-60-1
Narnatumab (anti-RON)
Narnatumab
1188275-92-4
Tisotumab (anti-F3)
Tisotumab
1418628-81-5
Zagotenemab (anti-Tau)
泽格特奈单抗
2019133-28-7
Vandortuzumab (anti-STEAP1)
万多妥珠单抗
1557989-52-2
Ladiratuzumab (anti-SLC39A6)
LADIRATUZUMAB (ANTI-SLC39A6)
1629760-28-6
Concizumab (anti-TFPI)
Concizumab
1312299-39-0
Serplulimab (anti-PDCD1)
SERPLULIMAB (斯鲁利单抗 )
2231029-82-4
Lexatumumab (anti-TNFRSF10B)
来沙木单抗
845816-02-6
Vunakizumab (anti-IL-17a)
Vunakizumab
1792181-33-9
Indusatumab (anti-GUCY2C)
英度妥单抗
1497400-26-6
Ulocuplumab (anti-CXCR4)
Ulocuplumab
1375830-34-4
Vantictumab (anti-FZD)
万替妥单抗
1345009-45-1
Fulranumab (anti-NGF)
FULRANUMAB ( 福拉奴单抗 )
902141-80-4
Ianalumab (anti-TNFRSF13C)
Ianalumab
1929549-92-7
Gevokizumab (anti-IL-1b)
吉伏组单抗
1129435-60-4
Pascolizumab (anti-IL-4)
Sb-240683
331243-22-2
Gemtuzumab (anti-CD33)
吉妥珠单抗奥唑米星
220578-59-6
Seribantumab (anti-ERBB3)
Seribantumab
1334296-12-6
Tarextumab (anti-NOTCH3)
Tarextumab
1359940-55-8
Zansecimab (anti-ANGPT2)
ZANSECIMAB (ANTI-ANGPT2)
2415205-37-5
Vorsetuzumab (anti-CD70)
Vorsetuzumab
1165740-62-4
Lemzoparlimab (anti-CD47)
来佐利单抗
2377483-71-9
Flanvotumab (anti-TYRP1)
Flanvotumab
1188277-05-5
Guselkumab (anti-IL-23)
古塞库单抗
1350289-85-8
Ixekizumab (anti-CTLA-8)
伊西贝单抗
1143503-69-8
Oxelumab (anti-TNFSF4)
OXELUMAB ( 奥塞芦单抗 )
1186098-83-8
Sirukumab (anti-IL-6)
SIRUKUMAB ( 西鲁库单抗 )
1194585-53-9
Ragifilimab (anti-TNFRSF18)
拉格芙利单抗
2207590-51-8
Depatuxizumab mafodotin (anti-EGFR)
Depatuxizumab Mafodotin
1585973-65-4
Belimumab (anti-TNFSF13B)
贝利木单抗
356547-88-1
Dostarlimab (anti-PD-1)
Dostarlimab
2022215-59-2
Daclizumab (anti-IL2RA)
达昔单抗
152923-56-3
Tinurilimab (anti-CEACAM6)
替奴瑞利单抗
2226224-30-0
Otilimab (anti-GM-CSF)
对照抗体
1638332-55-4
Ocrelizumab (anti-CD20)
Ocrelizumab
637334-45-3
Rilotumumab (anti-HGF)
RILOTUMUMAB ( 利妥木单抗 )
872514-65-3
Emibetuzumab (anti-MET)
Emibetuzumab
1365287-97-3
Enfortumab (anti-NECTIN4)
ENFORTUMAB (ANTI-NECTIN4)
1448664-46-7
Prezalumab (anti-B7-H2)
Prezalumab
1523164-68-2
Enoblituzumab (anti-CD276)
MGA271
1353485-38-7
Avdoralimab (anti-C5AR1)
AVDORALIMAB (艾朵利单抗 )
2226393-85-5
Labetuzumab govitecan (anti-CEACAM5)
Labetuzumab Govitecan
1469876-18-3
Girentuximab (anti-CA9)
吉妥昔单抗
916138-87-9
Datopotamab (anti-TROP2)
DATOPOTAMAB (ANTI-TROP2)
2267989-53-5
Imaprelimab (anti-CD146)
伊普利单抗
2014343-04-3
Abelacimab(anti-Factor XI)
Abelacimab
2098724-83-3
Dinutuximab (anti-GD2)
dinutuximab
1363687-32-4
Efalizumab (anti-ITGAL)
EFALIZUMABUM
214745-43-4
Carotuximab (anti-CD105)
Carotuximab
1268714-50-6
Ontamalimab (anti-MADCAM1)
Ontamalimab
2098790-40-8
Brazikumab (anti-IL-23)
Brazikumab
1610353-18-8
Enokizumab (anti-IL-9)
ENOKIZUMAB ( 依诺凯组单抗 )
909875-08-7
Eldelumab (anti-CXCL10)
Eldelumab
946414-98-8
Daxdilimab (anti-ILT7)
达司迪利单抗
2245966-28-1
Bermekimab (anti-IL-1a)
BERMEKIMAB (贝迈奇单抗 )
1401965-15-8
Ponsegromab (anti-GDF15)
PONSEGROMAB
2368950-15-4
Denintuzumab (anti-CD19)
地宁妥珠单抗
1630074-14-4
Inebilizumab (anti-CD19)
Inebilizumab
1299440-37-1
Eculizumab (anti-Complement C5)
托西珠单抗
219685-50-4
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
Copyright 2007© ChemicalBook. All rights reserved.